Spots Global Cancer Trial Database for indocyanine green solution
Every month we try and update this database with for indocyanine green solution cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Validation of ICG to Identify the Urethra During Rectal Surgery | NCT03204201 | Urethra Injury Rectal Cancer Surgery | Indocyanine Gre... | 18 Years - | Oxford University Hospitals NHS Trust | |
Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Lymph Node Mapping in Patients With Endometrial Cancer | NCT01818739 | Endometrial Can... | sentinel lymph ... indocyanine gre... isosulfan blue sentinel lymph ... | 18 Years - 85 Years | Ohio State University Comprehensive Cancer Center | |
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer | NCT05646316 | Stage I Uterine... | Diagnostic Imag... Indocyanine Gre... Minimally Invas... Pelvic Lymphade... Questionnaire A... Sentinel Lymph ... | 18 Years - | NRG Oncology | |
Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer | NCT02419807 | Stage I Breast ... Stage II Breast... | Indocyanine Gre... Technetium Tc-9... Lymphoscintigra... Axillary Lymph ... | - | Case Comprehensive Cancer Center | |
Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery | NCT02119858 | Stage IIA Prost... Stage IIB Prost... | indocyanine gre... diffuse optical... robot-assisted ... therapeutic lym... | 18 Years - 80 Years | City of Hope Medical Center | |
Lymph Node Mapping in Patients With Endometrial Cancer | NCT01818739 | Endometrial Can... | sentinel lymph ... indocyanine gre... isosulfan blue sentinel lymph ... | 18 Years - 85 Years | Ohio State University Comprehensive Cancer Center | |
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. | NCT01276054 | Lymphedema Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... | technetium Tc 9... methylene blue indocyanine gre... sentinel lymph ... axillary lymph ... bioimpedance sp... quality-of-life... lymphedema mana... | 18 Years - | University of Southern California | |
Validation of ICG to Identify the Urethra During Rectal Surgery | NCT03204201 | Urethra Injury Rectal Cancer Surgery | Indocyanine Gre... | 18 Years - | Oxford University Hospitals NHS Trust | |
To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer | NCT04514289 | Endometrial Can... Sentinel Lymph ... Indocyanine Gre... | Indocyanine gre... | 18 Years - 90 Years | Haseki Training and Research Hospital | |
Lymph Node Mapping in Patients With Endometrial Cancer | NCT01818739 | Endometrial Can... | sentinel lymph ... indocyanine gre... isosulfan blue sentinel lymph ... | 18 Years - 85 Years | Ohio State University Comprehensive Cancer Center | |
The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy | NCT04615806 | Esophageal Canc... Indocyanine Gre... | Indocyanine gre... | 18 Years - 75 Years | Fujian Medical University Union Hospital | |
Validation of ICG to Identify the Urethra During Rectal Surgery | NCT03204201 | Urethra Injury Rectal Cancer Surgery | Indocyanine Gre... | 18 Years - | Oxford University Hospitals NHS Trust | |
The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy | NCT04615806 | Esophageal Canc... Indocyanine Gre... | Indocyanine gre... | 18 Years - 75 Years | Fujian Medical University Union Hospital | |
Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study | NCT04987281 | Lung Non-Small ... Metastatic Mali... Stage I Lung Ca... | Computed Tomogr... Indocyanine Gre... Therapeutic Bro... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer | NCT04514289 | Endometrial Can... Sentinel Lymph ... Indocyanine Gre... | Indocyanine gre... | 18 Years - 90 Years | Haseki Training and Research Hospital | |
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery | NCT01939028 | Stage I Endomet... Stage II Endome... Stage III Endom... Stage IV Endome... | lymph node mapp... sentinel lymph ... isosulfan blue indocyanine gre... therapeutic con... lymphadenectomy | - | Case Comprehensive Cancer Center | |
Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery | NCT02119858 | Stage IIA Prost... Stage IIB Prost... | indocyanine gre... diffuse optical... robot-assisted ... therapeutic lym... | 18 Years - 80 Years | City of Hope Medical Center |